Survodutide

What is Survodutide

Survodutide is a dual GLP-1 and glucagon receptor agonist being studied for its effects on weight loss and metabolic control. It is part of a new class of compounds designed to suppress appetite and increase energy expenditure.

Benefits of Survodutide
- Supports obesity and metabolic research  
- May enhance fat oxidation and reduce appetite  
- Dual receptor activity for better glucose control  
- Investigated for liver health in NAFLD models  

How to Use Survodutide
Previous research dosages used: 0.1mg to 5mg per week administered via subcutaneous injection. Study protocols depend on subject type and desired endpoints.